Abstract
Ma Xing Shi Gan Decoction (MXD), a classical traditional Chinese medicine prescription, is widely used for the treatment of upper respiratory tract infection. However, the effect of MXD against particulate matters with diameter of less than 2.5 μm (PM2.5) induced lung injury remains to be elucidated. In this study, rats were stimulated with PM2.5 to induce lung injury. MXD was given orally once daily for five days. Lung tissues were harvested to assess pathological changes and edema. Myeloperoxidase (MPO) activity and malonaldehyde (MDA) content in lung were determined to evaluate the degree of injury. To assess the barrier disruption, the bronchoalveolar lavage fluid (BALF) was collected to determine the total protein content and count the number of neutrophils and macrophages. For evaluating the activation of macrophage in lung tissue, CD68 was detected using immunohistochemistry (IHC). The levels of inflammatory factors including tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and interleukin-6 (IL-6) in BALF and serum were measured. In vitro, a PM2.5-activated RAW 264.7 macrophages inflammatory model was introduced. To evaluate the protective effect of MXD-medicated serum, the cell viability and the release of inflammatory factors were measured. The effects of MXD on the High mobility group box-1/Toll-like receptor 4/Nuclear factor-kappa B (HMGB1/TLR4/NFκB) pathway in lung tissue and RAW 264.7 cells were assessed by Western blot. For further confirming the protective effect of MXD was mediated by inhibiting the HMGB1/TLR4/NFκB pathway, RAW 264.7 cells were incubated with MXD-medicated serum alone or MXD-medicated serum plus recombinant HMGB1 (rHMGB1). MXD significantly ameliorated the lung injury in rats, as evidenced by decreases in the pathological score, lung edema, MPO activity, MDA content, CD68 positive macrophages number, disruption of alveolar capillary barrier and the levels of inflammatory factors. In vitro, MXD-medicated serum increased cell viability and inhibited the release of inflammatory cytokines. Furthermore, MXD treatment was found to inhibit HMGB1/TLR4/NFκB signal pathway both in vivo and in vitro. Moreover, the protection of MXD could be reversed by rHMGB1 in RAW 264.7. Taken together, these results suggest MXD protects rats from PM2.5 induced acute lung injury, possibly through the modulation of HMGB1/TLR4/NFκB pathway and inflammatory responses.
Highlights
Exposure to respirable urban air particles poses a serious threat to human health across the world (Englert, 2004; Brook et al, 2010; Schneider et al, 2010; Zheng et al, 2015; McGuinn et al, 2019)
The regulatory effect was again reversed in Ma Xing Shi Gan Decoction (MXD)-medicated serum plus recombinant HMGB1 (rHMGB1) group (p < 0.01). These results demonstrate that the incubation of MXDmedicated serum significantly alleviates inflammatory reaction caused by PM2.5 in RAW264.7 cell by antagonizing the function of High mobility group box 1 (HMGB1) and the mechanism involved in the regulation of downstream Toll-like receptor 4 (TLR4)/Myeloid differentiation factor 88 (MyD88)/Nuclear factor-kappa B (NFκB) signaling pathway
The present study demonstrated that treatment with MXD could protect against PM2.5 induced injury both in vivo and in vitro
Summary
Exposure to respirable urban air particles poses a serious threat to human health across the world (Englert, 2004; Brook et al, 2010; Schneider et al, 2010; Zheng et al, 2015; McGuinn et al, 2019). The main phagocyte in lung tissue protects lung tissue against microorganism or particles via phagocytosis (Lukacs et al, 1995). When high particulate burdens are deposited and accumulated in the lung, alveolar macrophages will be over-activated and release excessive amounts of inflammatory factors which plays a key factor during the occurrence and development of lung injury (Asimakopoulos et al, 1999; Jacobson et al, 2005; Kallapur and Jobe, 2006; Herold et al, 2011). MXD is widely used in clinic for treatment of acute upper respiratory tract infection in China (Liao et al, 2017). It remains unknown whether MXD has protective effects against PM2.5 induced acute lung injury
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
